Routes ofadministration By mouth CAS Number 147116-64-1 Route Oral administration | ATC code none Molar mass 454.65 g/mol | |
 | ||
Legal status In general: uncontrolled Synonyms CJ-11,974; (2S,3S)-2-Diphenylmethyl-3-[(5-isopropyl-2-methoxybenzyl)amino]quinuclidine | ||
Ezlopitant (INN, code name CJ-11,974) is an NK1 receptor antagonist. It has antiemetic and antinociceptive effects. Pfizer was developing ezlopitant for the treatment of irritable bowel syndrome but it appears to have been discontinued.
References
Ezlopitant Wikipedia(Text) CC BY-SA